SI1494649T1 - Formulacije megestrola v obliki nanodelcev - Google Patents

Formulacije megestrola v obliki nanodelcev

Info

Publication number
SI1494649T1
SI1494649T1 SI200332121T SI200332121T SI1494649T1 SI 1494649 T1 SI1494649 T1 SI 1494649T1 SI 200332121 T SI200332121 T SI 200332121T SI 200332121 T SI200332121 T SI 200332121T SI 1494649 T1 SI1494649 T1 SI 1494649T1
Authority
SI
Slovenia
Prior art keywords
nanoparticulate megestrol
megestrol formulations
formulations
nanoparticulate
megestrol
Prior art date
Application number
SI200332121T
Other languages
English (en)
Inventor
Douglas Hovey
John Pruitt
Tuula Ryde
Original Assignee
Alkermes Pharma Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alkermes Pharma Ireland Ltd filed Critical Alkermes Pharma Ireland Ltd
Priority claimed from EP03723991A external-priority patent/EP1494649B1/en
Publication of SI1494649T1 publication Critical patent/SI1494649T1/sl

Links

SI200332121T 2002-04-12 2003-04-14 Formulacije megestrola v obliki nanodelcev SI1494649T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US37168002P 2002-04-12 2002-04-12
US43034802P 2002-12-03 2002-12-03
EP03723991A EP1494649B1 (en) 2002-04-12 2003-04-14 Nanoparticulate megestrol formulations
PCT/US2003/011277 WO2003086354A1 (en) 2002-04-12 2003-04-14 Nanoparticulate megestrol formulations

Publications (1)

Publication Number Publication Date
SI1494649T1 true SI1494649T1 (sl) 2012-04-30

Family

ID=45998682

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200332121T SI1494649T1 (sl) 2002-04-12 2003-04-14 Formulacije megestrola v obliki nanodelcev

Country Status (1)

Country Link
SI (1) SI1494649T1 (sl)

Similar Documents

Publication Publication Date Title
IL165332A0 (en) Nanoparticulate fibrate formulations
AU2003301807A2 (en) Nanoparticulate fibrate formulations
IL162642A0 (en) Formulations
GB2407268B (en) Sunscreen compositions
AU2003301516A8 (en) Antifungal formulations
AU2003295693A8 (en) Improved sunscreen compositions
AP2004003119A0 (en) Substituted hydroxyethylamines
GB0323701D0 (en) Formulations
IL166740A0 (en) Substituted heterocyclylpyrimidines
GB2407642B (en) Rheometer
SI1487778T1 (sl) Substituirani 4-aminocikloheksanoli
GB0325383D0 (en) Oral formulations
GB0218194D0 (en) Solid formulations
EP1554017A4 (en) TRAVEL MASK
GB0307765D0 (en) Tissue-adhesive formulations
GB0214147D0 (en) Formulations
SI1494649T1 (sl) Formulacije megestrola v obliki nanodelcev
GB0217787D0 (en) C ompounds
PL377325A1 (pl) Podstawione benzodioksepiny
GB2385795B (en) Putt conceder
GB0218567D0 (en) Formulations
GB0318503D0 (en) Formulations
GB0319551D0 (en) Formulations
GB0319549D0 (en) Formulations
GB0318871D0 (en) Tissue-adhesive formulations